NCT07539831

Brief Summary

This observational study aims to evaluate the effect of menstrual cycle phase on optic nerve sheath diameter (ONSD) in women undergoing elective laparoscopic gynecologic surgery. Patients will be grouped according to menstrual cycle phase as follicular or luteal. ONSD measurements will be performed perioperatively, and postoperative nausea and vomiting as well as postoperative cognitive function will also be assessed. The study is designed to investigate whether hormonal variations during the menstrual cycle are associated with differences in intracranial pressure reflected by ONSD measurements and postoperative outcomes

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
11mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Apr 2026Apr 2027

First Submitted

Initial submission to the registry

April 7, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2027

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

April 7, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Optic Nerve Sheath DiameterLaparoscopic Gynecologic SurgeryMini-Mental State ExaminationVerbal Descriptive ScaleFollicular PhaseLuteal Phase

Outcome Measures

Primary Outcomes (1)

  • Optic Nerve Sheath Diameter

    The primary outcome is the comparison of optic nerve sheath diameter (ONSD) between women in the follicular phase and those in the luteal phase of the menstrual cycle undergoing elective laparoscopic gynecologic surgery. ONSD will be measured ultrasonographically in the supine position. For each eye, three horizontal and three vertical measurements will be obtained and averaged.

    Before induction of anesthesia, during surgery, and at the end of surgery

Secondary Outcomes (2)

  • Postoperative Nausea and Vomiting

    Within 24 hours after surgery

  • Postoperative Cognitive Function

    Preoperative period and 24 hours after surgery

Study Arms (2)

Follicular Phase

Women undergoing elective laparoscopic gynecologic surgery during the follicular phase of the menstrual cycle (approximately days 12-14). Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.

Luteal Phase

Women undergoing elective laparoscopic gynecologic surgery during the luteal phase of the menstrual cycle (approximately days 20-25). Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women aged 18 to 45 years with ASA physical status I-II who are scheduled for elective laparoscopic gynecologic surgery at Konya City Hospital. Participants will be observed according to menstrual cycle phase (follicular or luteal phase).

You may qualify if:

  • Female patients aged 18 to 45 years
  • Scheduled for elective laparoscopic gynecologic surgery
  • Menstrual cycle in the follicular phase or luteal phase
  • American Society of Anesthesiologists (ASA) physical status I-II

You may not qualify if:

  • Irregular menstrual cycle (e.g., polycystic ovary syndrome, early menopause, hypothalamic amenorrhea)
  • Pregnancy or breastfeeding
  • Neurological disease associated with intracranial pressure changes
  • Glaucoma or another eye disease associated with high intraocular pressure
  • Previous brain surgery
  • Uncontrolled hypertension or severe cardiovascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • MAHMUT TUTAR, MD

    Konya City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MAHMUT TUTAR, MD

CONTACT

MAHMUT TUTAR, md

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Anesthesiology and Reanimation, Konya City Hospital

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 20, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

March 3, 2027

Study Completion (Estimated)

April 5, 2027

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations